Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Qyuns Therapeutics Co., Ltd. Class H ( (HK:2509) ) has shared an announcement.
Qyuns Therapeutics Co., Ltd. has announced the composition of its board of directors and their respective roles within the company. This announcement outlines the executive, non-executive, and independent non-executive directors, as well as their participation in various board committees, which may impact the company’s strategic direction and governance.
More about Qyuns Therapeutics Co., Ltd. Class H
Qyuns Therapeutics Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. The company focuses on developing therapeutic solutions, although specific products or market focus are not detailed in the announcement.
YTD Price Performance: 21.68%
Average Trading Volume: 82,866
Technical Sentiment Signal: Strong Buy
For detailed information about 2509 stock, go to TipRanks’ Stock Analysis page.